Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

The NetherlandsBack to the Netherlands

Clinical trials in Beek Lb

5 clinical trials in Beek Lb, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Beek Lb at a glance
5
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Beek Lb

Open in trial search

Cardiovascular disorder+2

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Arteriosclerosis

Not yet recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Dermatitis atopic

Not recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not recruiting
Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Adalimumab
  • Sponsor:Eli Lilly & Co.

Dermatitis atopic

Not recruiting
Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Beek Lb

What the registry says about research in the country

01 Beek Lb
Cardiovascular Diseases
Clinical research in Beek Lb is strongly focused on cardiovascular disease, with studies exploring ways to lower the risk of serious heart-related events in people living with type 2 diabetes, hypertension, and established heart disease. Improving protection against major cardiovascular events Studying atherosclerotic cardiovascular disease and related risk factors Evaluating treatments for people with elevated Lp(a) These trials are designed to test new treatment approaches and better understand how to reduce heart and vascular complications over time.
Immune System Diseases
Research in immune system diseases includes trials for inflammatory conditions such as atopic dermatitis and rheumatoid arthritis, with the aim of improving symptom control and day-to-day quality of life. Assessing treatment effectiveness in atopic dermatitis Comparing options for rheumatoid arthritis care Reducing inflammation and improving patient outcomes The studies are helping investigators evaluate whether newer therapies can offer better relief than existing approaches for chronic immune-mediated diseases.
Metabolic and Cardiometabolic Risk
Several ongoing trials link metabolic health with heart protection, especially in people with type 2 diabetes and hypertension who also face elevated cardiovascular risk. Testing strategies that address both blood sugar and heart health Looking at combined risk reduction in cardiometabolic disease Supporting prevention of heart failure and urgent cardiac events This area reflects a broader effort to improve long-term outcomes by treating overlapping metabolic and cardiovascular conditions together.
Lipid-Related Cardiovascular Research
A key focus is the study of elevated Lp(a), an important inherited risk marker tied to future heart problems and atherosclerotic cardiovascular disease. Evaluating therapies aimed at lowering cardiovascular risk Studying whether new treatment options can reduce major events Advancing prevention research in high-risk adults These trials are centered on finding better ways to prevent serious outcomes before they occur.
Inflammation and Vascular Safety
Some studies are also examining how treatments used in rheumatoid arthritis may compare with standard options in terms of safety, including risks related to the blood vessels. Comparing treatment choices in chronic inflammatory disease Monitoring vascular safety concerns Supporting informed decisions in long-term therapy This research helps clarify how to balance effectiveness and safety for patients who need ongoing treatment.
Back to the NetherlandsAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.